Company Overview

ICON plc is a world-leading clinical research organization providing outsourced development and commercialization services to pharmaceutical, biotechnology, and medical device innovators.

The organization specializes in the strategic design, operational execution, and biometric management of clinical programs spanning Phase I first-in-human studies through Phase IV post-marketing commitments.

With operations in over 50 countries, ICON integrates advanced data analytics, site management infrastructure, and decentralized clinical trial platforms to optimize protocol delivery.